We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




白细胞计数预测肾脏疾病预后

By LabMedica International staff writers
Posted on 08 Jul 2011
血液中淋巴细胞数或许可用作肾细胞癌(RCC)的一个预后指标。

淋巴细胞是白细胞的一种,在临床实验室中可通过常规方法计数,数目少可能意味着免疫系统受到抑制。

来自美国宾夕法尼亚州费城Fox Chase癌症中心(www.fccc.edu)的医疗肿瘤专家对500多名最常见RCC亚型——透明细胞RCC患者的数据进行了评估,这些患者于1994年至2009年间在Fox Chase癌症中心接受了肾脏摘除手术。专家发现,手术前三个月内的低淋巴细胞计数与预后不良存在明确关系。

科学家们发现较低的淋巴细胞水平往往伴随着较高的肿瘤等级、较晚的病理肿瘤分期、远处转移以及较高的恶性肿瘤(TNM)分期, TNM分期是一种评估肿瘤分期、扩散至局部淋巴结和远处转移的复合指标。他们还发现低计数与较低的总体存活率存在关联,即便考虑患者年龄、肿瘤分期和转移的影响也是如此。

研究论文的第一作者、Fox Chase癌症中心的医疗肿瘤研究员Sunil Saroha医学博士称:“一直以来,研究人员都希望找到可用于术前预后的标志物。最好能够在术前了解肿瘤是否会恶化,以及我们需要采用何种程度的治疗手段,而根本目的在于实现个性化治疗。”这一简单测试可以真正有助于在术前确定患者是否存在极高恶化风险以及当前疗法是否可能效果不佳。

在美国,每年近六万人被诊断为肾癌,其中许多患者会通过手术摘除病变的肾,但此过程对老年患者以及存在其它健康问题的患者相当危险。不幸的是,在手术摘取肿瘤样本并进行评估之前肾癌患者的预后常难以确定。例如,对于淋巴细胞计数并不低甚至可能相当健康的RCC年轻患者,医生可能会决定不施行更加激进的疗法,如手术和化疗。这项研究在2011年6月5日于美国伊利诺伊州芝加哥市举办的美国临床肿瘤学会年会上作了通报。

Related Links:
Fox Chase Cancer Center >>> www.fccc.edu
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
HPV Test
Allplex HPV28 Detection
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A new study identifies distinct metabolomic signatures in maternal blood associated with both the timing and type of early birth (Image credit: iStock)

Maternal Blood Biomarkers Identify Risk of Preterm and Early-Term Birth

Preterm and early-term births can lead to lasting complications because vital organs continue to mature during the final weeks of pregnancy. Babies born too soon face increased risks of breathing difficulties,... Read more

Molecular Diagnostics

view channel
Image: Spatial profiling of muscle-invasive bladder cancer reveals how distinct tumor cell states are organized within individual tumors (Image Credit: Shutterstock)

Spatial Map Guides Treatment Selection in Muscle-Invasive Bladder Cancer

Muscle-invasive bladder cancer is clinically heterogeneous, with patients often responding very differently to therapy. Existing biomarkers do not fully explain these disparities, limiting precision treatment... Read more

Microbiology

view channel
Image: Burkholderia pseudomallei is a soil-dwelling bacterium that causes melioidosis, a severe and potentially fatal infection that remains difficult to diagnose (Image Credit: Gavin Koh/Wikimedia Commons, CC BY-SA 4.0)

Stronger Laboratory Services Support Timely Melioidosis Diagnosis Amid Global Spread

Melioidosis, a potentially fatal infection caused by Burkholderia pseudomallei, remains difficult to recognize because its symptoms can mimic tuberculosis and other illnesses. The disease is considered... Read more

Industry

view channel
Image

QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

QIAGEN (Venlo, Netherlands) has introduced additions to its QIAcuity dPCR ecosystem that focus on gene expression, expanded assay content, and workflow standardization for life sciences and biopharma users.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.